Carisma Therapeutics, Inc.

暂不支持查看OTC详情

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Carisma Therapeutics宣布首席执行官Steven Kelly将于11月15日离职
  美股速递 · 2025-10-16
  Carisma Therapeutics宣布首席执行官Steven Kelly将于11月15日离职
- 根据SEC文件显示，Modernatx将向Carisma Therapeutics支付400万美元且无需承担后续财务义务
  美股速递 · 2025-09-18
  根据SEC文件显示，Modernatx将向Carisma Therapeutics支付400万美元且无需承担后续财务义务
- Carisma Therapeutics, Inc.盘中异动早盘股价大跌9.57%
  市场透视 · 2025-09-04
  Carisma Therapeutics, Inc.盘中异动早盘股价大跌9.57%
- Carisma Therapeutics, Inc.盘中异动股价大跌5.02%
  市场透视 · 2025-08-09
  Carisma Therapeutics, Inc.盘中异动股价大跌5.02%
- 这家公司裁员95%公司仅剩6人
  制药界 · 2025-08-08
  这家公司裁员95%公司仅剩6人
- Carisma Therapeutics, Inc.盘中异动急速下跌6.29%报0.286美元
  市场透视 · 2025-08-07
  Carisma Therapeutics, Inc.盘中异动急速下跌6.29%报0.286美元
- Carisma Therapeutics, Inc.7月8日成交额为26.06万美元
  市场透视 · 2025-07-09
  Carisma Therapeutics, Inc.7月8日成交额为26.06万美元
- Carisma Therapeutics, Inc.7月7日成交额为20.09万美元
  市场透视 · 2025-07-08
  Carisma Therapeutics, Inc.7月7日成交额为20.09万美元
- Carisma Therapeutics, Inc.盘中异动早盘股价大跌6.29%
  市场透视 · 2025-03-10
  Carisma Therapeutics, Inc.盘中异动早盘股价大跌6.29%
- Carisma Therapeutics, Inc.盘中异动早盘股价大涨5.00%报0.420美元
  市场透视 · 2025-03-06
  Carisma Therapeutics, Inc.盘中异动早盘股价大涨5.00%报0.420美元
- Carisma Therapeutics, Inc.盘中异动早盘急速拉升6.93%
  市场透视 · 2025-02-26
  Carisma Therapeutics, Inc.盘中异动早盘急速拉升6.93%
- Carisma Therapeutics, Inc.盘中异动急速跳水5.00%
  市场透视 · 2025-02-25
  Carisma Therapeutics, Inc.盘中异动急速跳水5.00%
- Carisma Therapeutics, Inc.盘中异动股价大跌8.43%报0.451美元
  市场透视 · 2025-02-18
  Carisma Therapeutics, Inc.盘中异动股价大跌8.43%报0.451美元
- Carisma Therapeutics, Inc.盘中异动大幅下跌5.84%报0.447美元
  市场透视 · 2025-02-14
  Carisma Therapeutics, Inc.盘中异动大幅下跌5.84%报0.447美元
- Carisma Therapeutics, Inc.盘中异动股价大跌5.08%报0.439美元
  市场透视 · 2025-02-10
  Carisma Therapeutics, Inc.盘中异动股价大跌5.08%报0.439美元
- Carisma Therapeutics, Inc.盘中异动股价大涨8.00%
  市场透视 · 2025-02-07
  Carisma Therapeutics, Inc.盘中异动股价大涨8.00%
- Carisma Therapeutics, Inc.盘中异动早盘快速拉升6.72%报0.495美元
  市场透视 · 2025-02-05
  Carisma Therapeutics, Inc.盘中异动早盘快速拉升6.72%报0.495美元
- Carisma Therapeutics, Inc.盘中异动大幅跳水6.26%报0.431美元
  市场透视 · 2025-02-03
  Carisma Therapeutics, Inc.盘中异动大幅跳水6.26%报0.431美元
- Carisma Therapeutics, Inc.盘中异动早盘股价大跌6.25%
  市场透视 · 2025-01-31
  Carisma Therapeutics, Inc.盘中异动早盘股价大跌6.25%
- Carisma Therapeutics, Inc.盘中异动大幅下跌6.80%
  市场透视 · 2025-01-30
  Carisma Therapeutics, Inc.盘中异动大幅下跌6.80%
公司概况
公司名称
Carisma Therapeutics, Inc.
所属市场
PINK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.sesenbio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
CARISMA Therapeutics Inc.于2008年2月25日在特拉华州法律下成立。该公司是一家临床阶段细胞治疗公司，专注于利用专有的CAR-M细胞治疗平台开发用于治疗癌症和严重疾病的转化免疫疗法。该公司创建了一个全面的细胞治疗平台，使工程化巨噬细胞和单核细胞的治疗用途成为可能，属于白细胞的一个亚群，称为髓细胞。
- 2025-12-16
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-12-15
  自愿退市
  Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
  Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
- 2025-12-05
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report

暂不提供行情数据

Carisma Therapeutics, Inc.

公司概况

热议股票